Patent ID: 11945872
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 8:
9. The antibody or antigen-binding fragment thereof of claim 1 comprising: (a) a HCDR1 domain having the amino acid sequence of SEQ ID NO: 24; (b) a HCDR2 domain having the amino acid sequence of SEQ ID NO: 46; (c) a HCDR3 domain having the amino acid sequence of SEQ ID NO: 60; (d) a LCDR1 domain having the amino acid sequence of SEQ ID NO: 50; (e) a LCDR2 domain having the amino acid sequence of SEQ ID NO: 64; and (f) a LCDR3 domain having the amino acid sequence of SEQ ID NO: 66.